Medical profiteering: The economics of methadone dispensation

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 11, 2009, Pages 1093-1094

  Nosyk, Bohdan ^a   Anis, Aslam H ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

CANADA; DRUG COST; DRUG MARKETING; DRUG USE; HUMAN; MAINTENANCE THERAPY; NOTE; PHARMACY; PRESCRIPTION; PROFIT; WITHDRAWAL SYNDROME; ECONOMICS; LEGAL ASPECT; OPIATE ADDICTION; PATIENT ATTITUDE; PATIENT CARE; PHARMACOECONOMICS; REVIEW; STATISTICS;

CANADA; DRUG PRESCRIPTIONS; ECONOMICS, PHARMACEUTICAL; HUMANS; METHADONE; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT CARE TEAM;

EID: 67049088052     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081513     Document Type: Note

References (8)

1. Tomlinson K. Pharmacy paid addict kickback: hidden camera. CBCnews.ca; 2008. Available: www.cbc.ca/canada/british-columbia/story/2008/09/07/bc- prescription-for-profit.html?ref=rss&loomia-si=t0:a16:g2:r1:c0.135526 (accessed 2009 Jan. 9).
2. Stitzer M, Petry N. Contingency management for treatment of substance abuse. Annu Rev Clin Psychol 2006;2:411-434 (Pubitemid 43799812)
3. Hutchinson SJ, Gore SM, Taylor A, et al. Extent and contributing factors of drug expenditure of injectors in Glasgow. Multi-site city-wide cross-sectional study. Br J Psychiatry 2000;176:166-172 (Pubitemid 32734843)
4. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York (NY): Springer-Verlag; 1991.
5. Kerr T, Marsh D, Li K, et al. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 2005;80:329-335 (Pubitemid 41660854)
6. Becker GS, Murphy KM. A theory of rational addiction. J Polit Econ 1988;96:675-700.
7. Bretteville-Jensen AL. Addiction and discounting. J Health Econ 1999;18:393-407.
8. Zarkin GA, Dunlap LJ, Hicks KA, et al. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ 2005;14:1133-1150 (Pubitemid 41645377)